T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$3.76B |
| 2 |
Cigna
CI
|
+$1.44B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$1.26B |
| 4 |
Occidental Petroleum
OXY
|
+$763M |
| 5 |
Danaher
DHR
|
+$762M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$2.46B |
| 2 |
Wynn Resorts
WYNN
|
+$1.11B |
| 3 |
Netflix
NFLX
|
+$1.03B |
| 4 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$975M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$909M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.87% |
| 2 | Financials | 13.64% |
| 3 | Consumer Discretionary | 13.54% |
| 4 | Industrials | 10.67% |
| 5 | Technology | 10.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LNCE
1901
DELISTED
Snyders-Lance, Inc.
LNCE
| $610K | ﹤0.01% |
18,910
| – | – |
|
1902
GATX Corp
GATX
$6.34B
| $609K | ﹤0.01% |
11,450
+1,300
| +13% | +$73.8K |
|
1903
Agree Realty
ADC
$9.25B
| $607K | ﹤0.01% |
20,800
+1,600
| +8% | +$49.5K |
|
1904
OneSpan
OSPN
$609M
| $604K | ﹤0.01% |
20,000
-3,000
| -13% | -$81.5K |
|
|
DMC
1905
Del Monte Corp
DMC
$1.42B
| $603K | ﹤0.01% |
15,600
| – | – |
|
1906
H.B. Fuller
FUL
$3.24B
| $603K | ﹤0.01% |
14,840
| – | – |
|
|
MGLN
1907
DELISTED
Magellan Health Services, Inc.
MGLN
| $603K | ﹤0.01% |
8,600
| – | – |
|
1908
Stock Yards Bancorp
SYBT
$2.64B
| $602K | ﹤0.01% |
23,882
| – | – |
|
|
NUVA
1909
DELISTED
NuVasive, Inc.
NUVA
| $602K | ﹤0.01% |
12,700
| – | – |
|
|
SNBR
1910
DELISTED
Sleep Number
SNBR
| $600K | ﹤0.01% |
19,950
| – | – |
|
1911
Tetra Tech
TTEK
$9.09B
| $599K | ﹤0.01% |
116,875
| – | – |
|
|
PINC
1912
DELISTED
Premier
PINC
| $588K | ﹤0.01% |
15,300
-800
| -5% | -$30K |
|
|
EXL
1913
DELISTED
EXCEL TRUST , INC COM STK
EXL
| $588K | ﹤0.01% |
37,265
+3,227
| +9% | +$50.7K |
|
|
UPL
1914
DELISTED
Ultra Petroleum Corp. Common Stock
UPL
| $587K | ﹤0.01% |
46,860
| – | – |
|
|
PDM
1915
Piedmont Realty Trust
PDM
$1.19B
| $586K | ﹤0.01% |
33,300
-4,300
| -11% | -$76.4K |
|
1916
American States Water
AWR
$3.49B
| $581K | ﹤0.01% |
15,552
+433
| +3% | +$16.7K |
|
1917
Park National Corp
PRK
$3.72B
| $581K | ﹤0.01% |
6,655
+500
| +8% | +$42.7K |
|
|
ITG
1918
DELISTED
Investment Technology Group Inc
ITG
| $580K | ﹤0.01% |
23,400
+9,300
| +66% | +$264K |
|
1919
Cal-Maine
CALM
$3.86B
| $579K | ﹤0.01% |
11,100
+4,500
| +68% | +$221K |
|
1920
Dillards
DDS
$9.93B
| $579K | ﹤0.01% |
5,500
| – | – |
|
|
CNW
1921
DELISTED
CON-WAY INC.
CNW
| $579K | ﹤0.01% |
15,100
| – | – |
|
|
CXP
1922
DELISTED
COLUMBIA PROPERTY TRUST, INC.
CXP
| $574K | ﹤0.01% |
23,400
-2,900
| -11% | -$76.6K |
|
1923
3D Systems Corp
DDD
$603M
| $573K | ﹤0.01% |
29,376
-49,449
| -63% | -$1.19M |
|
|
ELNK
1924
DELISTED
EarthLink Holdings Corp.
ELNK
| $571K | ﹤0.01% |
76,170
+16,200
| +27% | +$98.2K |
|
1925
Synchrony
SYF
$25.8B
| $570K | ﹤0.01% |
17,300
-3,600
| -17% | -$115K |
|
Similar funds
T. Rowe Price Associates's Q2 2015 Portfolio in Review
As of Q2 2015, T. Rowe Price Associates held 2,615 positions worth $486B, up 0.44% from $484B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
T. Rowe Price Associates's Q2 2015 filing shows 76 new, 1,051 increased, 777 reduced and 79 closed positions. Its largest new stake was Allergan plc: 548,825 shares worth $570M. The largest sale was PHARMACYCLICS INC, an estimated $2.46B.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 21% a quarter earlier, followed by Financials and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2015 buy was Allergan plc: 548,825 shares worth $570M.
- T. Rowe Price Associates added most to Microsoft in Q2 2015, an estimated $3.76B increase.
- T. Rowe Price Associates's biggest Q2 2015 reduction was Wynn Resorts, cutting an estimated $1.11B.
- T. Rowe Price Associates fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $2.46B.
- T. Rowe Price Associates's ten largest holdings make up 14% of its $486B portfolio in Q2 2015.
- T. Rowe Price Associates opened 76 new positions and closed 79 in Q2 2015.
- T. Rowe Price Associates's portfolio value rose 0.44% quarter-over-quarter to $486B.
Based on T. Rowe Price Associates's 13F filing for Q2 2015, filed 14 Aug 2015.